The skeleton represents the organ most commonly affected by metastatic cancer. Clinical observation studies indicate that nearly one-third of skeletal metastases are located in the spine, making the vertebral column the leading osseous target for metastatic tumors.
Introduction
The skeleton represents the organ most commonly affected by metastatic cancer. Clinical observation studies indicate that nearly one-third of skeletal metastases are located in the spine, making the vertebral column the leading osseous target for metastatic tumors. 1 Furthermore, autopsy studies have shown that as many as 70% of patients with cancer have spinal metastases. 2 Spinal metastases with spinal cord compression occur in 5% to 14% of cancer patients, with an annual incidence of 20,000 cases in the United States. 3 Over the past several decades, the survival of patients with metastases to the skeletal system has trended toward improvement. Furthermore, the improvement in adjuvant therapy has led to a decrease in surgery for metastatic disease in favor of radiation therapy. 1 However, surgery continues to play a critical role in the treatment of metastatic spinal tumors. Advances in surgical techniques and instrumentation have resulted in improved outcomes and a broader spectrum of interventions available to patients. The goals of surgery remain largely palliative and include the preservation or restoration of neurologic function, mechanical stability and, rarely, oncologic control. Timely diagnosis and appropriate treatment selection are vital in optimizing the outcomes of treatment of metastatic spinal disease. The possible modes of metastatic tumor spread include transmission through the arterial or venous system, through the cerebrospinal fl uid, or via direct extension. The vertebral column receives an extensive arterial blood supply, making the hematogenous route the most common mode of tumor transmission. In addition, tumor cells may travel through the cerebrospinal fl uid, either after tumor extension into the subarachnoid space or after evacuation of intracranial metastases. 4 Finally, direct spread of the tumors from adjacent organs may result in metastatic invasion of the spine, with Pancoast tumor of the lungs being an example.
The spine harbors the overwhelming majority of metastases in the osseous elements, with various degrees of epidural extension. Metastatic tumors rarely occupy the intradural compartment. However, within the intradural compartment, intramedullary and extramedullary metastatic tumors have been described. Furthermore, a metastatic epidural tumor may rarely invade the intradural compartment by direct extension through the meninges. Metastatic tumors generally migrate to the thoracic and lumbar spine and, more rarely, to the cervical and sacral segments. Multifocal spinal disease is frequently encountered, without numerous contiguous and discrete levels of involvement.
Clinical Presentation
The principal functions of the spine include protection of the spinal cord and nerve roots and maintenance of the axial structural integrity. Tumor infi ltration may affect both of these functions, compromising neural elements and mechanical stability. The majority of spinal tumors present with pain, and in patients with known malignancies, any spinal pain symptom merits a thorough investigation. Pain in the thoracic spine warrants a particularly close investigation because degenerative disorders affect the thoracic spine much more rarely than the cervical or lumbar region.
Pain may be biological, radicular, or mechanical. Biological pain is generally believed to be associated with localized infl ammation initiated by the immune response and intrinsic tumor mediators. This pain is commonly described as a deep ache that is worse at night. Biological pain may be effectively treated with corticosteroids and other anti-infl ammatory medications and by tumoricidal treatments. Compression of individual nerve roots results in radicular pain, which generally presents as band-like, burning, or shooting pain in a dermatomal distribution. Radicular pain may be treated with direct nerve root decompression, radiation therapy, or various neuroleptic medications. Finally, loss of the structural integrity of the spine results in mechanical pain, which manifests with movement and positions that require axial loading of the spine, such as sitting or standing. Mechanical pain generally cannot be alleviated with pharmacologic or radiation therapy and requires surgical stabilization.
After pain, neurologic dysfunction represents the second most common presentation of metastatic spinal tumors. 5 Epidural extension of the tumor via direct growth or pathological fracture may compress the spinal cord, individual nerve roots, or the cauda equina. Compression of the spinal cord may result in various degrees of myelopathy, including limb weakness or ataxia, bowel and bladder dysfunction, gait instability, and diminished sensation below the sensory level of the tumor. Signs of myelopathy such as hyperrefl exia, clonus, or a positive Hoffmann or Babinski sign may be present on physical examination. Compression of individual nerve roots may result in dermatomal pain or paresthesia or weakness in the muscle groups innervated by the affected root. Finally, signifi cant compression at the level of the cauda equina may result in a triad of symptoms: urinary retention, saddle anesthesia, and lower extremity weakness.
Radiographic Studies
Magnetic resonance imaging (MRI) represents the gold standard in imaging of spinal tumors. It provides accurate information about the soft tissue and osseous structures, allowing sensitive and fairly specifi c detection of spinal metastases. In addition to accurately detecting vertebral tumors, it defi nes the extent of epidural extension. This provides information about the degree of spinal cord compression and edema as well as nerve root impingement and the condition of the ligaments, paraspinal muscles, and joints. Gadolinium injection generally provides additional defi nition of soft-tissue infi ltration by the tumor along with its vascularity.
Multidetector computed tomography (CT) has largely replaced plain radiographs as the fi rst-choice imaging modality of the spinal osseous structures. Modern scanners allow rapid imaging of the entire length of the spine, providing two-and three-dimensional reconstructions. Metastatic tumors may have a lytic, blastic, or mixed appearance on a CT scan. This information can be used as one of the determinants of spinal stability. Furthermore, the epidural component of tumor extension may be soft or the result of retropulsion of the posterior cortex. Although this distinction may be diffi cult to discern on MRI, CT imaging easily differentiates bone from soft-tumor extension. This fi nding may play a signifi cant role in determining whether the patient requires surgery or may successfully undergo radiation therapy. Finally, CT is instrumental in operative planning and postoperative imaging. It allows precise measurement of the width and length of the pedicle and vertebral body in order to establish the optimal screw measurements. CT is often used postoperatively to ensure appropriate placement of instrumentation, spinal alignment, and the degree of fusion.
CT myelography is an invaluable modality in determining the degree of epidural tumor extension in patients with spinal instrumentation, as the instrumentation artifact generally makes the spinal canal diffi cult to evaluate on MRI. CT myelography has largely become the standard part of stereotactic radiosurgery planning in patients with spinal instrumentation.
Nuclear scans of the entire body play an important role in screening for spinal metastases and in staging of systemic disease. Nuclear scintigraphy (bone scan) detects regions of remodeling in the skeletal system. Although remodeling may be associated with osseous tumors, it may also be the result of infl ammation, infection, or fractures. Thus, although this two-dimensional modality provides excellent sensitivity in the detection of osseous metastasis, it has fairly low specifi city.
Single-photon emission tomography (SPECT) allows three-dimensional imaging and provides superior sensitivity and specifi city in tumor diagnosis. It differentiates neoplasms from infl ammatory and infectious lesions by detailing the metabolic profi le of the lesion.
Finally, positron emission tomography (PET) employs tagged molecules to detect regions of increased uptake.
18 F-fl uoride detects regions of increased fl uoride uptake and thereby serves as a marker of skeletal remodeling. 18 Fluorodeoxyglucose ( 18 FDG) aggregates in regions of increased metabolic activity in the skeleton and soft tissues and signals regions of neoplastic, infl ammatory, or infectious activity. Both 18 F-PET and 18 FDG-PET scans have been shown to be useful in staging systemic disease in cancer patients in combination with CT and MRI. [6] [7] [8] [9] All of the nuclear modalities provide better defi nition of lytic and mixed lesions in comparison to sclerotic lesions. This is likely related to the acellular and thereby hypometabolic nature of sclerotic lesions.
Treatment Considerations
Improvements in surgical technique, radiation delivery, and pharmacologic therapy have signifi cantly improved the quality and duration of life for patients with cancer. Modern treatment of metastatic spinal tumors involves a multidisciplinary team of surgeons, radiation oncologists, medical oncologists, diagnostic and interventional radiologists, and rehabilitation medicine physicians. Our ability to treat systemic and localized tumor burden has dramatically improved over the past several decades, but the goal of treatment of metastatic spinal tumors remains largely palliative. Patients with metastatic cancer generally succumb to systemic complications, and aggressive treatment of spinal metastases has not been shown to reliably affect survival. The goals of treatment of metastatic spinal tumors include the restoration and preservation of neurologic function, spinal stability, pain relief, and local tumor control.
The current treatment algorithm for metastatic spinal tumors incorporates surgery, radiation therapy, and chemotherapy. The principal factors in treatment selection include neurologic, oncologic, mechanical, and systemic parameters (NOMS). 10 The neurologic consideration incorporates the degree of epidural tumor extension and the extent of myelopathy.
Epidural Extension and Neurologic Evaluation
The Weinstein-Boriani-Biagini staging system, 11 which was initially devised to describe primary vertebral tumors, has been used in the context of spinal metastases. This system divides the axial plane of the vertebral body into 5 concentric and 12 radiating segments. More recently, the Spine Oncology Study Group validated a 6-point scale specifi cally devised to describe metastatic spinal tumors. 12 Grade 0 are tumors confi ned to bone without epidural extension, grade 1 is epidural extension without spinal cord abutment, grade 2 is cord abutment or deformation with cerebrospinal fl uid remaining around the cord, and grade 3 is cord compression without any fl uid around the cord. Grade 1 tumors are further subdivided into 3 categories, depending on whether they deform the thecal sac or epidural fat. Grade 2 and 3 tumors are likely to result in neurologic defi cits and, with the exception of radiosensitive tumors, require surgical decompression. The presence of neurologic defi cits usually correlates with high-grade tumor extension.
Tumor Histology
The histology of the tumor plays a paramount role in determining the responsiveness of the tumor to radiation therapy and chemotherapy. Hematologic malignancies, small-cell lung carcinoma, and choriocarcinoma display sensitivity to radiation therapy and chemotherapy and rarely require open decompression. 13 Solid tumor metastases have a wide range of radiosensitivity. Breast carcinoma is sensitive to conventional external-beam radiation therapy (EBRT); colon and non-small cell lung carcinomas exhibit moderate radioresistance, and renal cancer, melanoma, and sarcoma demonstrate a high degree of resistance to conventional EBRT. Radioresistant tumors with moderate-to high-grade cord compression generally require surgical decompression. However, radiosensitive tumors, even with high-grade cord compression, usually can be treated with radiation therapy.
Spinal Instability
As metastatic tumors invade the vertebral body and posterior elements, they compromise the ability of the vertebrae to withstand mechanical loads, leading to instability. The defi nition of spinal stability in the setting of spinal tumors has been evolving. Earlier stability criteria relied on the 3-column model developed by Denis. 14 However, this model was established to determine spinal stability in the setting of spinal trauma. Tumor invasion and radiation affect the ligaments and paraspinal musculature differently from high-velocity trauma. Although the osse-ous fracture pattern may have a similar appearance, the stability of the spine may be entirely different.
One of the common defi ning features of spinal instability includes activity-related pain. Fisher et al 15 of the Spine Oncology Study Group incorporated the classic Panjabi and White defi nition of spinal instability and recently defi ned instability in the setting of metastatic disease as "loss of spinal integrity as a result of a neoplastic process that is associated with movement-related pain, symptomatic or progressive deformity, and/ or neural compromise under physiologic loads." They devised a 6-component scale to aid in the determination of instability in the setting of metastatic spinal disease, which incorporates location, quality of pain, alignment, radiographic appearance of the lesion, extent of vertebral body collapse, and posterior element involvement.
Tumors located in the junctional regions such as the occipitocervical, cervicothoracic, thoracolumbar, and lumbosacral junctions and in the mobile segments of the spine (C3 through C6 and L2 through L4) are more likely to be associated with instability. Pain relief with recumbency and movement-related or axial loading pain are considered symptomatic of instability. Furthermore, the presence of subluxation or translation, more than 50% vertebral body collapse, a lytic appearance, and bilateral invasion of facets and pedicles are radiographic markers associated with a higher likelihood of instability. An unstable spine in the setting of metastatic tumors requires surgical stabilization since radiation therapy or chemotherapy cannot restore stability, even if the tumor is treated successfully.
Systemic Considerations
Finally, the systemic tumor burden and medical comorbidities must be taken into account when determining whether a patient is an appropriate surgical candidate. Generally, the life expectancy of the patient should exceed 3 months, although this cutoff is fairly arbitrary. Most spinal operations last several hours and require infusions of large fl uid volumes and blood products. Thus, patients must be able to safely undergo general anesthesia, and metastases and other comorbidities must not preclude rapid postoperative extubation and mobilization.
Surgery
The role of surgery has varied in its prominence over the past several decades. Historically, patients underwent uninstrumented decompression and tumor resection. However, comparison of uninstrumented surgery with EBRT showed no difference in outcomes. Thus, radiation became a standard treatment in all patients with spinal metastases, with surgery being reserved for rare occasions. The evolution and popularization of spinal instrumentation have once again brought surgery to the forefront of treatment options.
A prospective randomized clinical trial conducted by Patchell et al 16 provides fairly convincing support for the role of surgery in the treatment of patients with spinal cord compression secondary to metastatic solid tumors. The multi-institutional trial included patients with a tissue-proven diagnosis of cancer with a single metastatic spinal tumor causing displacement of the spinal cord and at least a single neurologic sign or symptom, which included pain. Patients with hematologic or germ-cell tumors and those who were paraplegic for more than 48 hours were excluded from the study. The protocol randomized patients into 2 arms in a nonblinded fashion. All patients received high-dose dexamethasone at the time of randomization. The radiation group underwent 30 Gy in 10 fractions. Patients in the surgical group underwent an operation, with the goal of achieving circumferential decompression, and went on to receive the 30-Gy radiation treatment within 14 days of the operation. The study did not place any restrictions or requirements on the type of surgery. The investigators terminated the trial after interim data analysis demonstrated clear superiority of the surgical group in the primary endpoint of the study, which was the ability to walk after treatment. The ambulation rate in the group that underwent surgery was 84%, with the patients retaining their ability to ambulate for a median duration of 122 days. Of the patients who were ambulatory prior to the entry into the study, 94% retained ambulation after surgery, and 62% of the patients who were nonambulatory at the time of recruitment regained the ability to walk. Patients in the surgical arm maintained continence for a median of 156 days and their American Spinal Injury Association (ASIA) classifi cation and Frankel grade for a median of 566 days. The 30-day mortality rate was 6%. Furthermore, a systematic review of the literature revealed ambulatory rates that ranged from 74% to 100% after surgery, with 57% to 82% of nonambulatory patients regaining ambulation. 17 Improvement in pain has been observed in more than 90% of patients who underwent instrumented stabilization. 18 The primary defi ciencies of the study by Patchell et al 16 include the undemanding defi nition of ambulation (only 4 steps), the obsolete defi nition of stability and inclusion of unstable patients in the radiation group, and the lack of a stabilization requirement in the surgical arm. Furthermore, the uniform treatment of all patients with conventional EBRT and lack of spinal stereotactic radiosurgery underestimate the effectiveness of radiation treatment.
Patients with spinal metastases may undergo a wide range of surgical interventions, ranging from limited decompression to radical tumor excision. Tomita et al 19 devised a 10-point scale that took into account tumor histology and the extent of visceral and bone metastases to determine the goal of intervention and thereby the aggressiveness of surgery. Thus, according to the authors, the treatment goal of patients with rapidly growing tumors, such as those of the lungs or stomach, and systemic metastases is largely short-term palliation or terminal care; this makes these patients candidates for limited palliative decompression surgery or only supportive care. However, patients with slow-growing tumors, such as those of the breasts or thyroid, and solitary spinal metastasis are candidates for wide or marginal excision of the tumor, with the goal of long-term control.
Tokuhashi et al 20 proposed a 15-point scale that considered 6 parameters: the patient's performance status, the number of extraspinal bone metastases, the number of vertebral metastases, the extent of visceral metastases, tumor histology, and the extent of neurologic defi cit. Their scale correlated with the expected survival of the patients. They recommend excisional surgery for patients with a favorable tumor histology, good functional and neurologic scores, and limited metastatic disease, and thereby an expected survival longer than 1 year. Patients expected to survive less than 6 months were recommended for conservative treatment, and those expected to survive between 6 months and 1 year were recommended for limited palliative surgery. As suggested by these scoring systems, the excision strategy may range from limited intralesional curettage to en bloc wide marginal excision of the tumor. The overwhelming majority of modern surgical procedures for spinal metastases involve instrumented spinal stabilization.
Depending on the location of the tumor and the goal of the operation, an anterior, posterior, or lateral approach, or a combination of them, may be used. The majority of tumors invade the vertebral body; therefore, the anterior approach may often represent the most direct route to the lesion. Access to the craniocervical junction may be achieved with a transoral or transmandibular approach. However, these approaches carry a high morbidity risk and are rarely used in the setting of metastatic tumors.
Recently, transnasal and transcervical approaches to the craniocervical junction have been devised. The transcervical approach also provides access to the subaxial and upper thoracic spine. Ventral access to the T1 through T4 levels is complicated by the great vessels and mediastinal organs. 21 However, when necessary, manubriotomy, sternotomy, or a trap-door approach may be implemented to access the upper thoracic region. T5 through L1 generally can be accessed through a thoracotomy, 22 and L2 through L5 can be accessed through a retroperitoneal approach. Frequently, cancer patients have had previous radiation therapy or surgery to the neck, thorax, or abdominal cavities. Furthermore, lung or abdominal metastases may disrupt normal tissue planes and complicate ventral approaches. In such instances, approach surgeons can be consulted to provide additional expertise in dissection. Alternatively, posterior approaches can be implemented.
The posterior approach to the spine allows direct access to the spinal cord, obviating the extensive bone resection generally required with anterior approaches. 18 Furthermore, T3 through T12 nerve roots may generally be sacrifi ced without signifi cant morbidity, facilitating transpedicular access to the ventral elements of the vertebral column (Fig A-C) . Most spine surgeons have greater familiarity with the posterior approach to the spine, and thus the posterior approach represents the most commonly used route for spinal decompression and stabilization.
Various reconstruction instrumentation systems are available. Modern posterior stabilization systems generally involve multilevel pedicle instrumentation using titanium polyaxial screw-rod systems. 23 Ventral support is achieved using a variety of cages, which may be composed of titanium or polyetherketone (PEEK) 
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or polymethyl-methacrylate (PMMA) cement. 24 Furthermore, in addition to the traditional open surgical methods, current techniques involve a combination of percutaneous instrumentation, image guidance, and minimally invasive decompression techniques.
Vertebroplasty/Kyphoplasty
Numerous cement formulations, with PMMA being the most commonly used, can provide additional reinforcement to the vertebral body. The cement is generally injected into the vertebral body via a percutaneously placed needle and administered under continuous visualization with fl uoroscopy. Although vertebroplasty involves direct injection of the cement via a needle, during kyphoplasty an infl atable balloon is used to provide a void in the bone to inject the cement under low pressure and to attempt to restore the height of the vertebral body. The cement injection provides structural support to the vertebral body and pain relief, theoretically via thermoablation of nociceptive nerve endings.
A review of 97 cement augmentation procedures performed in 56 patients with various metastatic spinal tumors revealed that improvement or complete pain relief was achieved in 84% of the procedures. 25 Furthermore, these procedures may be effectively conducted in conjunction with spinal stereotactic radiosurgery to treat or prevent pathological compression fractures. 26 The most common complications of cement injection are extravasation into the venous plexus or the epidural space and embolization via the vascular system. However, patients with extravasation are generally asymptomatic and do not require any intervention.
Indications for Surgery and Vertebroplasty
All patients with mechanical instability require a spinal stabilization procedure because radiation therapy and chemotherapy do not restore spinal stability. Depending on the degree of instability and tumor infi ltration, instrumented stabilization or vertebroplasty can be performed. Kyphoplasty or vertebroplasty provides fairly durable and consistent pain relief for patients with tumors that infi ltrate only the vertebral body, without signifi cant involvement of the posterior elements and an epidural tumor burden. If the tumor infi ltrates the posterior elements or signifi cantly extends into the spinal canal, an instrumented stabilization is generally required to restore stability and provide adequate pain relief.
Generally, patients with spinal metastases without spinal instability or high-grade cord compression can be effectively treated with radiation therapy. However, as evidenced by the study by Patchell et al, 16 spinal cord compression secondary to solid tumor spinal metastases represents an indication for surgical decompression. Patients with radiosensitive tumors such as lymphoma and multiple myeloma can be treated with radiation therapy regardless of the degree of cord compression, provided they do not meet the criteria of spinal instability.
Conclusions
Current surgical treatment of metastatic spinal tumors incorporates interventions ranging from limited decompression or percutaneous cement injection to a radical resection of the tumor with complex reconstruction and stabilization. The advances in adjuvant treatments necessitate a multidisciplinary approach that optimizes the combination of surgery, radiation therapy, and chemotherapy to maximize tumor control and minimize the morbidity of treatment. Although the role of surgery remains largely palliative, appropriate adjuvant therapy may provide excellent localized tumor control. The goals of operative intervention in patients with metastatic spinal tumors include the restoration and preservation of neurologic function, stabilization of the vertebral column, and pain relief. In appropriately selected patients, surgery has provided a signifi cant improvement on quality of life, pain control, functional status, and the ability to undergo adjuvant therapy.
